Johnson & Johnson (JNJ): Price and Financial Metrics

JNJ POWR Grades

• Stability is the dimension where JNJ ranks best; there it ranks ahead of 96.36% of US stocks.
• The strongest trend for JNJ is in Growth, which has been heading up over the past 177 days.
• JNJ's current lowest rank is in the Momentum metric (where it is better than 17.42% of US stocks).

JNJ Stock Summary

• With a market capitalization of $435,655,108,602, JOHNSON & JOHNSON has a greater market value than 99.84% of US stocks.
• JNJ's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 3,403.26 -- higher than 99.29% of US-listed equities with positive expected earnings growth.
• The volatility of JOHNSON & JOHNSON's share price is greater than that of just 0.91% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to JNJ, based on their financial statements, market capitalization, and price volatility, are UNH, TSM, V, XOM, and WMT.
• JNJ's SEC filings can be seen here. And to visit JOHNSON & JOHNSON's official web site, go to www.jnj.com.

JNJ Valuation Summary

• In comparison to the median Healthcare stock, JNJ's price/sales ratio is 142.11% higher, now standing at 4.6.
• JNJ's EV/EBIT ratio has moved up 2.2 over the prior 243 months.

Below are key valuation metrics over time for JNJ.

JNJ Growth Metrics

The 2 year net income to common stockholders growth rate now stands at 15.52%.
• Its 4 year net income to common stockholders growth rate is now at 8.81%.
• The 4 year revenue growth rate now stands at 15.55%.

Over the past 33 months, JNJ's revenue has gone up $13,882,000,000.

The table below shows JNJ's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	95,588	23,582	18,366
2022-03-31	94,880	23,315	19,830
2021-12-31	93,775	23,410	20,878
2021-09-30	91,446	26,021	17,880
2021-06-30	89,190	26,114	17,767
2021-03-31	84,214	24,252	15,115

JNJ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• JNJ has a Quality Grade of B, ranking ahead of 92.45% of graded US stocks.
• JNJ's asset turnover comes in at 0.52 -- ranking 78th of 682 Pharmaceutical Products stocks.
• CBIO, CLSD, and ABBV are the stocks whose asset turnover ratios are most correlated with JNJ.

The table below shows JNJ's key quality metrics over time.